Medicare to cover Dexcom G5 Mobile

The Centers for Medicare & Medicaid Services will cover DexCom Inc.'s (Nasdaq: DXCM) continuous glucose monitoring system Dexcom G5 Mobile. Shares of the medical device maker leaped $17.52 to close at $85.13.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.